Dr Visalini Nair-Shalliker

Dr Visalini Nair-Shalliker

Senior Research Fellow
E: visalinin@nswcc.org.au


Dr Visalini Nair-Shalliker’s research is focussed on identifying environmental, lifestyle and molecular risk factors of prostate cancer, to improve our understanding on the interactions between modifiable and non-modifiable risk factors. She completed a PhD in Epidemiology which examined the relationship between sun exposure, vitamin D and development of prostate cancer. This led to her current involvement in a randomised control trial of vitamin D supplementation in men with prostate cancer.


  • PhD, University of Sydney
  • Master of Public Health, University of Sydney
  • Master of Science, Deakin University
  • Bachelor of Science (Hons), Deakin University


A phase II randomised controlled trial of high dose Vitamin D in localised prostate cancer cases with intermediate risk of progression (Pros-D), Project Grant, Prostate Cancer Foundation of Australia

Academic affiliations

  • Honorary Fellow, Macquarie University
  • Adjunct Senior Lecturer, The University of Sydney

Current student supervision

Mr Ben Gallagher, PhD Candidate, The University of Sydney
Mr Ankur Arya, PhD Candidate, The University of Sydney

Visalini is available to supervise PhD students enrolled at Macquarie University and The University of Sydney.

Key publications

Nair-Shalliker V, Bang B, Egger S, Clements M, Gardiner F, Kricker A, Seibel M, Chambers S, Kimlin M, Armstrong BK and Smith DP. Post-treatment levels of plasma 25- and 1,25-dihydroxy vitamin D and mortality in men with aggressive prostate cancer. Sci Rep. DOI : 10.1038/s41598-020-62182-w

Kimlin MG, Youlden DR, Brodie AM, DiSipio T, Youl P, Nair-Shalliker V, Baade PD. Risk of Second Primary Cancer in Survivors of In Situ Melanoma. J Invest Dermatol. 2019 Apr;139(4):842-847. doi: 10.1016/j.jid.2018.11.001. Epub 2018 Nov 10.

Cole-Clark D, Nair-Shalliker V, Bang A, Rasiah K, Chalasani V, Smith DP. An initial melanoma diagnosis may increase the subsequent risk of prostate cancer: Results from the New South Wales Cancer Registry. Sci Rep. 2018 May 8;8(1):7167. doi: 10.1038/s41598-018-25408-6.

Nair-Shalliker V, Bang A, Weber M, Goldsbury DE, Caruana M, Emery J, Banks E, Canfell K, O’Connell DL, Smith DP. Factors associated with prostate specific antigen testing in Australians: Analysis of the New South Wales 45 and Up Study. Sci Rep. 2018 Mar 9;8(1):4261. doi: 10.1038/s41598-018-22589-y.

Nair-Shalliker V, Egger S, Chrzanowska A, Mason R, Waite L, Le Couteur D, Seibel MJ, Handelsman DJ, Cumming R, Smith DP, Armstrong BK. Associations between sun sensitive pigmentary genes and serum prostate specific antigen levels. PLoS One. 2018 Mar 8;13(3):e0193893. doi: 10.1371/journal.pone.0193893. eCollection 2018.

Nunez, C., Bauman, A., Egger, S., Sitas, F. & Nair-Shalliker, V. Obesity, physical activity and cancer risks: Results from the Cancer, Lifestyle and Evaluation of Risk Study (CLEAR). Cancer Epidemiol 47, 56-63, doi:10.1016/j.canep.2017.01.002 (2017).

Nair-Shalliker, V. et al. Adult body size, sexual history and adolescent sexual development, may predict risk of developing prostate cancer: Results from the New South Wales Lifestyle and Evaluation of Risk Study (CLEAR). Int J Cancer 140, 565-574, doi:10.1002/ijc.30471 (2017).

More publications by Dr Visalini Nair-Shalliker